Last update 31 May 2025

Arformoterol/budesonide

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
UI-030
Target
β2-adrenergic receptor
Action
agonists
Mechanism
β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists)
Therapeutic Areas
Respiratory Diseases
Active Indication
Pulmonary Disease, Chronic Obstructive
Inactive Indication
COVID-19
Originator Organization
KOREA UNITED PHARM, Inc.KOREA UNITED PHARM, Inc.
Active Organization
KOREA UNITED PHARM, Inc.KOREA UNITED PHARM, Inc.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-
Login to view timeline

Structure/Sequence

Molecular FormulaC23H30N2O10
InChIKeyFCSXYHUNDAXDRH-OKMNHOJOSA-N
CAS Registry200815-49-2
View All Structures (2)

Related

1
Clinical Trials associated with Arformoterol/budesonide
NCT05055414
/ Unknown statusPhase 2
A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel, Phase 2 Study to Evaluate the Efficacy and Safety of UI030 in COVID-19 Patients
100 Clinical Results associated with Arformoterol/budesonide
Login to view more data
100 Translational Medicine associated with Arformoterol/budesonide
Login to view more data
100 Patents (Medical) associated with Arformoterol/budesonide
Login to view more data
100 Deals associated with Arformoterol/budesonide
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 2-
KOREA UNITED PHARM, Inc.KOREA UNITED PHARM, Inc.
01 Nov 2021
Pulmonary Disease, Chronic ObstructivePreclinical
South Korea
KOREA UNITED PHARM, Inc.KOREA UNITED PHARM, Inc.
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free